|
|
||||||||
Exercise Physiology Laboratory, Department of Physiology, University of Arizona, Tucson, Arizona 85721-0093
Received 12 July 1996; accepted in final form 23 December 1996.
Tipton, Charles M., and Lisa A. Sebastian. Dobutamine
as a countermeasure for reduced exercise performance of rats exposed to
simulated microgravity. J. Appl.
Physiol. 82(5): 1607-1615, 1997.
Post-spaceflight
results and findings from humans and rodents after conditions of bed
rest or simulated microgravity indicate maximum exercise performance is
significantly compromised. However, the chronic administration of
dobutamine (a synthetic adrenomimetic) to humans in relevant
experiments improves exercise performance by mechanisms that prevent
the decline in peak O2 consumption (
O2 peak) and reduce
the concentration of lactic acid measured in the blood. Although
dobutamine restores maximum
O2
values in animals participating in simulated microgravity
studies, it is unknown whether injections of this
1-,
1-, and
2-adrenoceptor agonist in rats
will enhance exercise performance. To investigate this, adult male rats
were assigned to three experimental groups: caged control receiving
saline; head-down, tail-suspended (HDS) receiving saline (HDS-S); and
an HDS group receiving dobutamine hydrochloride injections (1.8 mg/kg
twice daily per rat). Treadmill tests were performed before suspension,
at 14 days, and after 21 days.
O2 peak, run time,
and the rate of rise in colonic temperature (heating index) were
evaluated after 14 days, whereas at 21 days, hemodynamic responses
(heart rate, systolic blood pressure, and double product) were
determined during submaximal exercise with blood pH, blood gases, and
lactic acid concentration values obtained during maximal exercise. In
contrast to the results for the HDS-S rats, dobutamine administration
did restore
O2 peak and "normalized" lactic acid concentrations during maximal
exercise. However, daily injections were unable to enhance exercise
performance aspects associated with treadmill run time, the mechanical
efficiency of running, the heating index, or the retention of muscle
and body mass. These simulated microgravity findings suggest that dobutamine's potential value as a countermeasure for postflight maximal performance or for egress emergencies is limited and that other
countermeasures must be considered.
tail suspension and dobutamine; aerobic capacity and suspension; temperature regulation; suspension and lactic acid
This article has been cited by other articles:
![]() |
N. D. Vaziri, Y. Ding, D. S. Sangha, and R. E. Purdy Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance J Appl Physiol, July 1, 2000; 89(1): 338 - 344. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |